1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Point-Of-Care Diagnostics / Testing (POCT) Market
2.2. Global Point-Of-Care Diagnostics / Testing (POCT) Market, By Products, 2023 (US$ Million)
2.3. Global Point-Of-Care Diagnostics / Testing (POCT) Market, By End-users, 2023 (US$ Million)
2.4. Global Point-Of-Care Diagnostics / Testing (POCT) Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023

3. Point-Of-Care Diagnostics / Testing (POCT) Market: Competitive Analysis
3.1. Market Positioning of Key Point-Of-Care Diagnostics / Testing (POCT) Market Vendors
3.2. Strategies Adopted by Point-Of-Care Diagnostics / Testing (POCT) Market Vendors
3.3. Key Industry Strategies
4. Point-Of-Care Diagnostics / Testing (POCT) Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Point-Of-Care Diagnostics / Testing (POCT) Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Point-Of-Care Diagnostics / Testing (POCT) Market: By Products, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Glucose Monitoring
5.3.2. Cardiac Markers
5.3.3. Infectious Diseases Testing
5.3.4. Cholesterol Testing
5.3.5. Coagulation Monitoring
5.3.6. Pregnancy And Fertility Testing
5.3.7. Hematology Testing
5.3.8. Blood Gas Testing
5.3.9. Others (Fecal Occult Testing, Cancer Markers, Urinalysis Testing, Drugs Of Abuse Testing, etc.)

6. Point-Of-Care Diagnostics / Testing (POCT) Market: By End-users, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Clinics
6.3.2. Home
6.3.3. Laboratories
6.3.4. Assisted living healthcare facilities
6.3.5. Hospitals


7. North America Point-Of-Care Diagnostics / Testing (POCT) Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Point-Of-Care Diagnostics / Testing (POCT) Market: By Products, 2022-2032, USD (Million)
7.3. Point-Of-Care Diagnostics / Testing (POCT) Market: By End-users, 2022-2032, USD (Million)
7.4.Point-Of-Care Diagnostics / Testing (POCT) Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Point-Of-Care Diagnostics / Testing (POCT) Market: By Products, 2022-2032, USD (Million)
7.4.1.1.2. Point-Of-Care Diagnostics / Testing (POCT) Market: By End-users, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Point-Of-Care Diagnostics / Testing (POCT) Market: By Products, 2022-2032, USD (Million)
7.4.1.2.2. Point-Of-Care Diagnostics / Testing (POCT) Market: By End-users, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Point-Of-Care Diagnostics / Testing (POCT) Market: By Products, 2022-2032, USD (Million)
7.4.1.3.2. Point-Of-Care Diagnostics / Testing (POCT) Market: By End-users, 2022-2032, USD (Million)

8. UK and European Union Point-Of-Care Diagnostics / Testing (POCT) Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Point-Of-Care Diagnostics / Testing (POCT) Market: By Products, 2022-2032, USD (Million)
8.3. Point-Of-Care Diagnostics / Testing (POCT) Market: By End-users, 2022-2032, USD (Million)
8.4.Point-Of-Care Diagnostics / Testing (POCT) Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Point-Of-Care Diagnostics / Testing (POCT) Market: By Products, 2022-2032, USD (Million)
8.4.1.1.2. Point-Of-Care Diagnostics / Testing (POCT) Market: By End-users, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Point-Of-Care Diagnostics / Testing (POCT) Market: By Products, 2022-2032, USD (Million)
8.4.1.2.2. Point-Of-Care Diagnostics / Testing (POCT) Market: By End-users, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Point-Of-Care Diagnostics / Testing (POCT) Market: By Products, 2022-2032, USD (Million)
8.4.1.3.2. Point-Of-Care Diagnostics / Testing (POCT) Market: By End-users, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Point-Of-Care Diagnostics / Testing (POCT) Market: By Products, 2022-2032, USD (Million)
8.4.1.4.2. Point-Of-Care Diagnostics / Testing (POCT) Market: By End-users, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Point-Of-Care Diagnostics / Testing (POCT) Market: By Products, 2022-2032, USD (Million)
8.4.1.5.2. Point-Of-Care Diagnostics / Testing (POCT) Market: By End-users, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Point-Of-Care Diagnostics / Testing (POCT) Market: By Products, 2022-2032, USD (Million)
8.4.1.6.2. Point-Of-Care Diagnostics / Testing (POCT) Market: By End-users, 2022-2032, USD (Million)

9. Asia Pacific Point-Of-Care Diagnostics / Testing (POCT) Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Point-Of-Care Diagnostics / Testing (POCT) Market: By Products, 2022-2032, USD (Million)
9.3. Point-Of-Care Diagnostics / Testing (POCT) Market: By End-users, 2022-2032, USD (Million)
9.4.Point-Of-Care Diagnostics / Testing (POCT) Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Point-Of-Care Diagnostics / Testing (POCT) Market: By Products, 2022-2032, USD (Million)
9.4.1.1.2. Point-Of-Care Diagnostics / Testing (POCT) Market: By End-users, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Point-Of-Care Diagnostics / Testing (POCT) Market: By Products, 2022-2032, USD (Million)
9.4.1.2.2. Point-Of-Care Diagnostics / Testing (POCT) Market: By End-users, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Point-Of-Care Diagnostics / Testing (POCT) Market: By Products, 2022-2032, USD (Million)
9.4.1.3.2. Point-Of-Care Diagnostics / Testing (POCT) Market: By End-users, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Point-Of-Care Diagnostics / Testing (POCT) Market: By Products, 2022-2032, USD (Million)
9.4.1.4.2. Point-Of-Care Diagnostics / Testing (POCT) Market: By End-users, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Point-Of-Care Diagnostics / Testing (POCT) Market: By Products, 2022-2032, USD (Million)
9.4.1.5.2. Point-Of-Care Diagnostics / Testing (POCT) Market: By End-users, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Point-Of-Care Diagnostics / Testing (POCT) Market: By Products, 2022-2032, USD (Million)
9.4.1.6.2. Point-Of-Care Diagnostics / Testing (POCT) Market: By End-users, 2022-2032, USD (Million)

10. Latin America Point-Of-Care Diagnostics / Testing (POCT) Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Point-Of-Care Diagnostics / Testing (POCT) Market: By Products, 2022-2032, USD (Million)
10.3. Point-Of-Care Diagnostics / Testing (POCT) Market: By End-users, 2022-2032, USD (Million)
10.4.Point-Of-Care Diagnostics / Testing (POCT) Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Point-Of-Care Diagnostics / Testing (POCT) Market: By Products, 2022-2032, USD (Million)
10.4.1.1.2. Point-Of-Care Diagnostics / Testing (POCT) Market: By End-users, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Point-Of-Care Diagnostics / Testing (POCT) Market: By Products, 2022-2032, USD (Million)
10.4.1.2.2. Point-Of-Care Diagnostics / Testing (POCT) Market: By End-users, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Point-Of-Care Diagnostics / Testing (POCT) Market: By Products, 2022-2032, USD (Million)
10.4.1.3.2. Point-Of-Care Diagnostics / Testing (POCT) Market: By End-users, 2022-2032, USD (Million)

11. Middle East and Africa Point-Of-Care Diagnostics / Testing (POCT) Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Point-Of-Care Diagnostics / Testing (POCT) Market: By Products, 2022-2032, USD (Million)
11.3. Point-Of-Care Diagnostics / Testing (POCT) Market: By End-users, 2022-2032, USD (Million)
11.4.Point-Of-Care Diagnostics / Testing (POCT) Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Point-Of-Care Diagnostics / Testing (POCT) Market: By Products, 2022-2032, USD (Million)
11.4.1.1.2. Point-Of-Care Diagnostics / Testing (POCT) Market: By End-users, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Point-Of-Care Diagnostics / Testing (POCT) Market: By Products, 2022-2032, USD (Million)
11.4.1.2.2. Point-Of-Care Diagnostics / Testing (POCT) Market: By End-users, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Point-Of-Care Diagnostics / Testing (POCT) Market: By Products, 2022-2032, USD (Million)
11.4.1.3.2. Point-Of-Care Diagnostics / Testing (POCT) Market: By End-users, 2022-2032, USD (Million)

12. Company Profile
12.1. Abbott Laboratories, Inc.
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Abaxis, Inc.
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Alere, Inc.
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Bayer AG
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Danaher Corporation
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Becton, Dickinson, And Company
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Johnson & Johnson
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Nipro Corporation
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Roche Diagnostics Limited
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Siemens Healthcare
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
12.11. Samsung Medison Co. Ltd.
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Portfolio
12.11.4. Strategic Initiatives